1-3 of 3
Donald L. Durden, MD, PhD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Dual Targeting of PI3Kdelta and BRD4 Sensitizes Acute Lymphoblastic Leukemia to Chemotherapy

Hye Na Kim, Cydney Nichols, Enzi Ji Jiang, MD PhD, Nour Abdel-Azim, Ariana Coba, DOnald L. Durden, MD PhD, Yong-Mi Kim, MD MPH, PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 1420.
https://doi.org/10.1182/blood-2018-99-116310
Published: 2018
Journal Articles

Wolinella Asparaginase as an Immunologically Distinct, Efficacious, and Potentially Less Toxic Asparaginase for Use in Lymphoid Malignancies.

Tanya C. Watt, MD, Frank G. Keller, MD, Donald L. Durden, MD, PhD
Journal: Blood
Blood (2007) 110 (11): 861.
https://doi.org/10.1182/blood.V110.11.861.861
Published: 2007
Journal Articles

A Vascular Targeted Pan PI-3 Kinase Inhibitor, SF1126 with Activity Against Multiple Myeloma In Vivo .

Pradip De, PhD, Qiong Peng, PhD, Nandini Dey, MD, Breanne McDermitt, MD, Xiaodong Peng, PhD, Joseph Garlich, PhD, Sagar Lonial, MD, Donald L. Durden, MD, PhD
Journal: Blood
Blood (2006) 108 (11): 244.
https://doi.org/10.1182/blood.V108.11.244.244
Published: 2006